Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
79.10
0.00 (0.00%)
Apr 2, 2025, 1:30 PM CST

Foresee Pharmaceuticals Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
1,3671,010689.51871.441,145
Upgrade
Short-Term Investments
75150-100125
Upgrade
Trading Asset Securities
---297.47351.68
Upgrade
Cash & Short-Term Investments
1,4421,160689.511,2691,622
Upgrade
Cash Growth
24.37%68.19%-45.66%-21.76%226.86%
Upgrade
Accounts Receivable
32.3365.9116.27--
Upgrade
Other Receivables
13.7622.1810.135.7313.97
Upgrade
Receivables
46.0988.0926.45.7313.97
Upgrade
Inventory
183.87126.8176.4124.8834.11
Upgrade
Prepaid Expenses
145.2723.5622.753.99.71
Upgrade
Other Current Assets
-192.5--6.62
Upgrade
Total Current Assets
1,8181,591915.061,3031,686
Upgrade
Property, Plant & Equipment
217.62135.01142.3991.19110.8
Upgrade
Other Intangible Assets
117.79126.81140.96155.14209.44
Upgrade
Long-Term Deferred Tax Assets
1.311.231.221.11.14
Upgrade
Other Long-Term Assets
4.97.76104.3990.5892.06
Upgrade
Total Assets
2,1591,8611,3041,6412,100
Upgrade
Accounts Payable
64.4212.1322.85--
Upgrade
Accrued Expenses
-120.7178.4761.6845.8
Upgrade
Short-Term Debt
150200--30.07
Upgrade
Current Portion of Long-Term Debt
----20.79
Upgrade
Current Portion of Leases
12.4115.1415.5210.29.38
Upgrade
Current Income Taxes Payable
8.8210.424.95--
Upgrade
Current Unearned Revenue
50.03105.481.010.781.52
Upgrade
Other Current Liabilities
107.536.966.381.7914.03
Upgrade
Total Current Liabilities
393.21470.83129.1774.45121.59
Upgrade
Long-Term Debt
92.92---63.24
Upgrade
Long-Term Leases
-13.1225.86.456.68
Upgrade
Long-Term Unearned Revenue
72.62131.67237.15239.1777.67
Upgrade
Long-Term Deferred Tax Liabilities
1.411.321.321.191.22
Upgrade
Total Liabilities
560.15616.93393.43321.26270.4
Upgrade
Common Stock
1,5481,3581,1821,1791,169
Upgrade
Additional Paid-In Capital
5,9064,6173,4243,3723,319
Upgrade
Retained Earnings
-5,811-4,730-3,693-3,221-2,651
Upgrade
Comprehensive Income & Other
-44.56-1.49-1.54-10.21-8.06
Upgrade
Shareholders' Equity
1,5991,245910.581,3201,829
Upgrade
Total Liabilities & Equity
2,1591,8611,3041,6412,100
Upgrade
Total Debt
255.33228.2641.3216.65130.15
Upgrade
Net Cash (Debt)
1,187931.42648.191,2521,492
Upgrade
Net Cash Growth
27.44%43.70%-48.24%-16.05%208.45%
Upgrade
Net Cash Per Share
8.647.325.4910.6714.71
Upgrade
Filing Date Shares Outstanding
140.88135.82118.17117.94116.94
Upgrade
Total Common Shares Outstanding
140.88135.82118.17117.94116.94
Upgrade
Working Capital
1,4241,120785.891,2291,565
Upgrade
Book Value Per Share
11.359.167.7111.1915.64
Upgrade
Tangible Book Value
1,4811,118769.621,1651,620
Upgrade
Tangible Book Value Per Share
10.518.236.519.8813.85
Upgrade
Machinery
-209.45171.58136.94144.58
Upgrade
Construction In Progress
-4.920.394.41.31
Upgrade
Leasehold Improvements
-30.447.717.717.71
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.